Family Medicine Initiative

APRIL 9, 2024

Yes, one year after stopping the medication, patients regain ½ – ⅔ of their previous weight loss: What are other clinical benefits? 4 Chronic Kidney Disease The FLOW trial randomized 3,534 patients with chronic kidney disease and type 2 diabetes and started treating them with s.c. mg or placebo in 2019. semaglutide 2.4

Diabetes 130

Diabetes Patients Medical Family Medicine 130

Physician's Weekly

JUNE 22, 2025

The primary endpoints included changes in body mass index (BMI), Hospital Anxiety and Depression Scale (HADS) scores, and Kansas City Cardiomyopathy Questionnaire Overall Summary Score (KCCQ-OSS) from baseline to 1 year.

Individual 52

Individual Diabetes Hospital Clinic 52

Physician's Weekly

JUNE 10, 2025

from Loma Linda University School of Medicine in California, and colleagues conducted a cross-sectional study from June 2019 to August 2023 at a single institution’s outpatient gynecology clinic involving 205 premenopausal women aged 18 to 54 years: 116 with AUB and 89 with normal menstrual cycles. Salcedo, D.O.,

Relationship 52

Relationship Clinic Medical Family Practice 52

Medical Xpress

JUNE 8, 2025

Long-term effects of pain in early life We collected data on the number of procedures, clinical exposures and sucrose doses from three NICUs across Canada. As is the case internationally, sucrose is used widely in New Zealand, but there is considerable variation in protocols of use across hospitals.

IT 59

IT Management Vaccination Medical 59

FDA Law

SEPTEMBER 13, 2021

A May 2019 CMS final rule that would have required drug TV advertisements to disclose the WAC of the drug was challenged by a group of pharmaceutical companies and vacated on statutory grounds by the D.C. Other legislative proposals included improving supply chain transparency.

Manufacturing 98

Manufacturing Supply Chain Patient-Centered Utilities 98